http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006050301-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7df6dd7219070cd615ab762834f4177c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_744f177c7cb88f3e8b180961b5a686f7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2005-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6c9d5f14a48469bcff0d10d6eed6ef1
publicationDate 2007-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006050301-A3
titleOfInvention Dye-free pharmaceutical suspensions and related methods
abstract A dye-free pharmaceutical suspension having a therapeutically effective amount of a first active agent consisting essentially of a first substantially water insoluble active agent, an effective amount of non-reducing sweetener; an effective amount of water; and an effective amount of a suspending system; and an effective amount of an opacifier, wherein the dye-free pharmaceutical suspension has a pH of from about 5 to about 6 and is substantially free of a reducing sugar and related methods.
priorityDate 2004-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0843998-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4427681-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5354556-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5112604-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 19.